Clinicopathological Evaluation of the Revised European-American Classification of Lymphoid Neoplasms (REAL) in Japan

References

• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., Wolf-Peeters C. D., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H-K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• The non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Suchi T., Tajima K., Nanba K., Wakasa H., Mikata A., Kikuchi M., Mori S., Watanabe S., Mohri N., Shamoto M., Harigaya K., Itagaki T., Matsuda M., Kirino Y., Takagi K., Fukunaga S. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma. A proposal of a new type. Acta. Patho. Jap 1979; 29: 755–776
   PubMedGoogle Scholar
• Pittaluga S., Bijnes L., Teodorovic I., Hagenbeek A., Meerwaldt J. H., Somers R., Thomas J., Noordijk E. M., Woolf-Peeters C. D. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group sub-typed according to the revised European-American classification of lymphoid neoplasms: A comparison with the Working Formulation. Blood 1996; 87: 4358–4367
   PubMed Web of Science ®Google Scholar
• The non-Hodgkin's Lymphoma Classification project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909–3918
   PubMed Web of Science ®Google Scholar
• Fisher R. I., Grogan T. M., Dahlberg S., Braziel R., Banks P., Nathwani B., Kjeldsberg C., Miller T. P. Clinical behavior of 2168 patients treated on Southwest Oncology Group (SWOG) protocols and reclassified according to the R.E.A.L. classification. Ann. Oncol 1996; 7: 3, (abstr 006, supl 3)
   Google Scholar
• Melnyk A., Rodriguez M. A., Pugh W. C., Cabanillas F. Evaluation of the R.E.A.L classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma (NHL). Proc. Am. Soc. Clin. Oncol 1996; 15: 413, (abstr 1262)
   Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K.C., Cleary M. L., Delsol G., Wolf-Peeters C. D., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H-K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. Lymphoma classification proposal: Clarification. Blood 1995; 85: 857–860
   PubMed Web of Science ®Google Scholar
• Hiddemann W., Longo D. L., Coiffier B., Fisher R. I., Cabanillas F., Cavalli F., Nadler L. M., De Vita V. T., Lister A., Armitage J. O. Lymphoma classification - The gap between biology and clinical management is closing. Blood 1996; 88: 4085–4089
   PubMed Web of Science ®Google Scholar
• Nakamura S., Seto M., Banno S., Suzuki S., Koshikawa T., Kitoh K., Kagami Y., Ogura M., Yatabe Y., Kojima M., Motoori T., Takahash T., Ueda R., Suchi T. Immunohistochemical analysis of cyclin Dl protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Jpn. J. Cancer Res 1994; 85: 1270–1279
   PubMedGoogle Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers I. W., Tubiana M. Report of the Hodgkin's disease staging classification committee. Conference on staging in Hodgkin's disease. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Bunn P. A., Jr., Lamberg S. I. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat. Rep 1979; 63: 725–728
   PubMedGoogle Scholar
• Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 457–480
   Web of Science ®Google Scholar
• The International Non-Hodgkin's Lymphoma Prognostic Project. A predictive model for aggressive non-Hodgkin's lymphoma. N. Engl. J. Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Cox D. R. Regression models and life tables. J. R. Stat. Soc. Ser. B 1972; 34: 187–202
   Web of Science ®Google Scholar
• Mohri N., Li C-C (1992) Malignant lymphomas, in two university hospitals in Tokyo. China-Japan medical conference. 1992. Vol 3: 478
   Google Scholar
• Stansfeld A., Diebold J., Kapanci Y., Kelenyi G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., Van Unnik J., Wright D. Updated Kiel classification of lymphoma. Lancet 1988; 1: 292–293
   PubMed Web of Science ®Google Scholar
• Nakamura S., Yatabe Y., Koshikawa T. Several issues on malignant lymphoma classification (in Japanese). Hematol. and Oncolo 1997; 35: 1–8
   Google Scholar
• Izumo T., Maseki N., Kaneko Y. An evaluation of REAL classification on malignant lymphoma in Japan (in Japanese). Jpn. J. Lymphoretic. Res 1996; 36: 145–156
   Google Scholar
• Ioachim H. L. Lymph Node Pathology, 2nd edn. J.B. Lippincott Company, Philadelphia 1994; 366–382
   Google Scholar